| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
| filingDate |
2019-09-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2022-01-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2022501425-A |
| titleOfInvention |
Edarabon precursor drug compounds and their pharmaceutical uses for the treatment or amelioration of degenerative or motor neurological disorders |
| abstract |
The present invention relates to a novel precursor drug (prodrug) of an edaravone compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same as an active ingredient, a degenerative neurological disorder and / or a motor neurological disorder thereof. Provide therapeutic or ameliorated pharmaceutical uses. |
| priorityDate |
2018-09-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |